{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T23:07:55Z","timestamp":1792624075279,"version":"4.5.0"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,5,17]]},"DOI":"10.1093\/cid\/ciy776","type":"journal-article","created":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T15:25:08Z","timestamp":1536247508000},"page":"1791-1797","source":"Crossref","is-referenced-by-count":412,"title":["Estimation of Direct Healthcare Costs of Fungal Diseases in the United States"],"prefix":"10.1093","volume":"68","author":[{"given":"Kaitlin","family":"Benedict","sequence":"first","affiliation":[{"name":"Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan R","family":"Jackson","sequence":"additional","affiliation":[{"name":"Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Chiller","sequence":"additional","affiliation":[{"name":"Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karlyn D","family":"Beer","sequence":"additional","affiliation":[{"name":"Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,9,10]]},"reference":[{"key":"2019051701003921800_CIT0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.idc.2015.10.004","article-title":"The global burden of fungal diseases","volume":"30","author":"Vallabhaneni","year":"2016","journal-title":"Infect Dis Clin North Am"},{"key":"2019051701003921800_CIT0002","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/j.1875-9114.2012.01124","article-title":"Cost of invasive fungal infections in the era of new diagnostics and expanded treatment options","volume":"32","author":"Dodds Ashley","year":"2012","journal-title":"Pharmacotherapy"},{"key":"2019051701003921800_CIT0003","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1016\/j.ajic.2010.06.009","article-title":"The economic costs to United States hospitals of invasive fungal infections in transplant patients","volume":"39","author":"Menzin","year":"2011","journal-title":"Am J Infect Control"},{"key":"2019051701003921800_CIT0004","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1046\/j.1524-4733.2002.51108.x","article-title":"The direct cost and incidence of systemic fungal infections","volume":"5","author":"Wilson","year":"2002","journal-title":"Value Health"},{"key":"2019051701003921800_CIT0005","doi-asserted-by":"crossref","first-page":"ofv219","DOI":"10.1093\/ofid\/ofv219","article-title":"Histoplasmosis-associated hospitalizations in the United States, 2001\u20132012","volume":"3","author":"Benedict","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"2019051701003921800_CIT0006","doi-asserted-by":"crossref","first-page":"e301","DOI":"10.1111\/j.1439-0507.2010.01903.x","article-title":"Hospital costs and outcomes among intravenous antifungal therapies for patients with invasive aspergillosis in the United States","volume":"54","author":"Kim","year":"2011","journal-title":"Mycoses"},{"key":"2019051701003921800_CIT0007","first-page":"368","article-title":"Hospitalized burden and outcomes of coccidioidomycosis: a nationwide analysis, 2005\u20132012","volume":"55","author":"Luo","year":"2017","journal-title":"Med Mycol"},{"key":"2019051701003921800_CIT0008","doi-asserted-by":"crossref","first-page":"e56269","DOI":"10.1371\/journal.pone.0056269","article-title":"Epidemiology of cryptococcal meningitis in the US: 1997\u20132009","volume":"8","author":"Pyrgos","year":"2013","journal-title":"PLoS One"},{"key":"2019051701003921800_CIT0009","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3201\/eid2301.161198","article-title":"Epidemiology of hospitalizations associated with invasive candidiasis, United States, 2002-20121","volume":"23","author":"Strollo","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"2019051701003921800_CIT0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2334-14-310","article-title":"Hospital days, hospitalization costs, and inpatient mortality among patients with mucormycosis: a retrospective analysis of US hospital discharge data","volume":"14","author":"Zilberberg","year":"2014","journal-title":"BMC Infect Dis"},{"key":"2019051701003921800_CIT0011","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/pds.960","article-title":"Trends in prescribing for vulvovaginal candidiasis in the United States","volume":"14","author":"McCaig","year":"2005","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2019051701003921800_CIT0012","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/j.1365-4632.2009.04025.x","article-title":"Cutaneous fungal infections in the United States: Analysis of the National Ambulatory Medical Care Survey (NAMCS) and National Hospital Ambulatory Medical Care Survey (NHAMCS), 1995\u20132004","volume":"48","author":"Panackal","year":"2009","journal-title":"Int J Dermatol"},{"key":"2019051701003921800_CIT0013","volume-title":"Healthcare Cost and Utilization Project","author":"National Inpatient Sample","year":"2014"},{"key":"2019051701003921800_CIT0014","author":"Centers for Disease Control and Prevention"},{"key":"2019051701003921800_CIT0015","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1093\/cid\/cix138","article-title":"Giardiasis diagnosis and treatment practices among commercially insured persons in the United States","volume":"64","author":"Beer","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2019051701003921800_CIT0016","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.amepre.2015.04.031","article-title":"Examining fluoroquinolone claims among gonorrhea-associated prescription drug claims, 2000\u20132010","volume":"49","author":"Owusu-Edusei","year":"2015","journal-title":"Am J Prev Med"},{"key":"2019051701003921800_CIT0017","author":"United States Department of Labor"},{"key":"2019051701003921800_CIT0018","author":"Centers for Medicare & Medicaid Services"},{"key":"2019051701003921800_CIT0019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2334-13-29","article-title":"Aspergillosis in Intensive Care Unit (ICU) patients: epidemiology and economic outcomes","volume":"13","author":"Baddley","year":"2013","journal-title":"BMC Infect Dis"},{"key":"2019051701003921800_CIT0020","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1086\/317487","article-title":"Burden of aspergillosis-related hospitalizations in the United States","volume":"31","author":"Dasbach","year":"2000","journal-title":"Clin Infect Dis"},{"key":"2019051701003921800_CIT0021","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1099\/jmm.0.000656","article-title":"Prevalence, healthcare resource utilization and overall burden of fungal meningitis in the United States","volume":"67","author":"Charalambous","year":"2018","journal-title":"J Med Microbiol"},{"key":"2019051701003921800_CIT0022","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-016-2023-z","article-title":"Prevalence, clinical and economic burden of mucormycosis-related hospitalizations in the United States: a retrospective study","volume":"16","author":"Kontoyiannis","year":"2016","journal-title":"BMC Infect Dis"},{"key":"2019051701003921800_CIT0023","doi-asserted-by":"crossref","first-page":"ofw268","DOI":"10.1093\/ofid\/ofw268","article-title":"Trends in hospitalizations related to invasive Aspergillosis and Mucormycosis in the United States, 2000\u20132013","volume":"4","author":"Vallabhaneni","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"2019051701003921800_CIT0024","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jaad.2006.05.048","article-title":"The burden of skin diseases: 2004 a joint project of the American Academy of Dermatology Association and the Society for Investigative Dermatology","volume":"55","author":"Bickers","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"2019051701003921800_CIT0025","doi-asserted-by":"crossref","first-page":"81","DOI":"10.12703\/P6-81","article-title":"Epidemiology of invasive fungal diseases on the basis of autopsy reports","volume":"6","author":"Dignani","year":"2014","journal-title":"F1000Prime Rep"},{"key":"2019051701003921800_CIT0026","unstructured":"Asti\n              L\n            , NewlandJ, ZerrD, et al\n          Multi-center validation of ICD-9 codes for candidemia in a pediatric population. In: Program and abstracts of the 48th Annual Meeting of the Infectious Diseases Society of America, Vancouver, 2010; poster number: 561. Available at: https:\/\/idsa.confex.com\/idsa\/2010\/webprogram\/Paper2463.html"},{"key":"2019051701003921800_CIT0027","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1086\/524324","article-title":"Comparison of the use of administrative data and an active system for surveillance of invasive aspergillosis","volume":"29","author":"Chang","year":"2008","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2019051701003921800_CIT0028","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jclinepi.2006.07.011","article-title":"Veteran\u2019s affairs hospital discharge databases coded serious bacterial infections accurately","volume":"60","author":"Schneeweiss","year":"2007","journal-title":"J Clin Epidemiol"},{"key":"2019051701003921800_CIT0029","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.3201\/eid1611.100475","article-title":"Enhanced surveillance of coccidioidomycosis, Arizona, USA, 2007\u20132008","volume":"16","author":"Tsang","year":"2010","journal-title":"Emerg Infect Dis"},{"key":"2019051701003921800_CIT0030","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0190-9622(98)70199-9","article-title":"Effect of onychomycosis on quality of life","volume":"38","author":"Drake","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"2019051701003921800_CIT0031","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/590004","article-title":"Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis","volume":"47","author":"Chamilos","year":"2008","journal-title":"Clin Infect Dis"},{"key":"2019051701003921800_CIT0032","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1086\/504810","article-title":"Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study","volume":"43","author":"Garey","year":"2006","journal-title":"Clin Infect Dis"},{"key":"2019051701003921800_CIT0033","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of Aspergillosis: 2016 update by the Infectious Diseases Society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2019051701003921800_CIT0034","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01909-17","article-title":"Diagnosing invasive candidiasis","author":"Clancy","year":"2018","journal-title":"J Clin Microbiol"},{"key":"2019051701003921800_CIT0035","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.clinthera.2015.03.021","article-title":"Economic comparison of an empirical versus diagnostic-driven strategy for treating invasive fungal disease in immunocompromised patients","volume":"37","author":"Barnes","year":"2015","journal-title":"Clin Ther"},{"key":"2019051701003921800_CIT0036","doi-asserted-by":"crossref","first-page":"e350","DOI":"10.1016\/j.ijid.2011.01.011","article-title":"Galactomannan-guided preemptive vs. empirical antifungals in the persistently febrile neutropenic patient: a prospective randomized study","volume":"15","author":"Tan","year":"2011","journal-title":"Int J Infect Dis"},{"key":"2019051701003921800_CIT0037","first-page":"585","article-title":"Prevalence and correlates of cryptococcal antigen positivity among AIDS patients--United States, 1986\u20132012","volume":"63","author":"McKenney","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2019051701003921800_CIT0038","doi-asserted-by":"crossref","first-page":"737","DOI":"10.2165\/11588370-000000000-00000","article-title":"Cost benefit and cost effectiveness of antifungal prophylaxis in immunocompromised patients treated for haematological malignancies: reviewing the available evidence","volume":"29","author":"Pechlivanoglou","year":"2011","journal-title":"Pharmacoeconomics"},{"key":"2019051701003921800_CIT0039","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/myc.12329","article-title":"Antifungal stewardship in daily practice and health economic implications","volume":"58","author":"Mu\u00f1oz","year":"2015","journal-title":"Mycoses"},{"key":"2019051701003921800_CIT0040","doi-asserted-by":"crossref","first-page":"797","DOI":"10.3201\/eid0705.010505","article-title":"Cost-effectiveness of a potential vaccine for Coccidioides immitis","volume":"7","author":"Barnato","year":"2001","journal-title":"Emerg Infect Dis"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/68\/11\/1791\/28653278\/ciy776.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T01:01:52Z","timestamp":1558054912000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/68\/11\/1791\/5094714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,10]]},"references-count":40,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2018,9,10]]},"published-print":{"date-parts":[[2019,5,17]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciy776","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,6,1]]},"published":{"date-parts":[[2018,9,10]]}}}